Next Article in Journal
Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes
Next Article in Special Issue
Performance Parameters and Characterizations of Nanocrystals: A Brief Review
Previous Article in Journal
Drug Delivery Approaches for the Treatment of Cervical Cancer
Previous Article in Special Issue
Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2016, 8(3), 24; doi:10.3390/pharmaceutics8030024

TPGS-Stabilized Curcumin Nanoparticles Exhibit Superior Effect on Carrageenan-Induced Inflammation in Wistar Rat

1
Pharmaceutics Research Group, School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia
2
Research Center for Nanosciences and Nanotechnology, Bandung Institute of Technology, Bandung 40132, Indonesia
3
Pharmacology and Clinical Pharmacy Research Group, School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia
4
Faculty of Pharmacy, University of Surabaya, Surabaya 60293, Indonesia
*
Author to whom correspondence should be addressed.
Academic Editor: Leena Peltonen
Received: 4 June 2016 / Revised: 26 July 2016 / Accepted: 8 August 2016 / Published: 16 August 2016
(This article belongs to the Special Issue Nanocrystals)
View Full-Text   |   Download PDF [5766 KB, uploaded 16 August 2016]   |  

Abstract

Curcumin, a hydrophobic polyphenol compound derived from the rhizome of the Curcuma genus, has a wide spectrum of biological and pharmacological applications. Previously, curcumin nanoparticles with different stabilizers had been produced successfully in order to enhance solubility and per oral absorption. In the present study, we tested the anti-inflammatory effect of d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS)-stabilized curcumin nanoparticles in vivo. Lambda-carrageenan (λ-carrageenan) was used to induce inflammation in rats; it was given by an intraplantar route and intrapelurally through surgery in the pleurisy test. In the λ-carrageenan-induced edema model, TPGS-stabilized curcumin nanoparticles were given orally one hour before induction and at 0.5, 4.5, and 8.5 h after induction with two different doses (1.8 and 0.9 mg/kg body weight (BW)). Sodium diclofenac with a dose of 4.5 mg/kg BW was used as a standard drug. A physical mixture of curcumin-TPGS was also used as a comparison with a higher dose of 60 mg/kg BW. The anti-inflammatory effect was assessed on the edema in the carrageenan-induced paw edema model and by the volume of exudate as well as the number of leukocytes reduced in the pleurisy test. TPGS-stabilized curcumin nanoparticles with lower doses showed better anti-inflammatory effects, indicating the greater absorption capability through the gastrointestinal tract. View Full-Text
Keywords: curcumin; nanoparticle; inflammation; λ-carrageenan; nanoparticle permeability; Biopharmaceutical Class System (BCS) 4 curcumin; nanoparticle; inflammation; λ-carrageenan; nanoparticle permeability; Biopharmaceutical Class System (BCS) 4
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Rachmawati, H.; Safitri, D.; Pradana, A.T.; Adnyana, I.K. TPGS-Stabilized Curcumin Nanoparticles Exhibit Superior Effect on Carrageenan-Induced Inflammation in Wistar Rat. Pharmaceutics 2016, 8, 24.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top